MARIAFE MANALANG VITAL

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family LAS VEGAS, NV NPI 1629314786

General Payments — all program years on this page

$1,158.42

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 34
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $500.68 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $500.6815

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $139.396
Acerta Pharma LLC $133.652
Gilead Sciences, Inc. $121.811
Merck Sharp & Dohme Corporation $56.053
Amgen Inc. $21.151
Otsuka America Pharmaceutical, Inc. $14.921
Alkermes, Inc. $13.711

By program year

Program yearAmountRecords
2021 $337.739
2022 $12.781
2023 $307.239
2024 $500.6815

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104362607 AstraZeneca Pharmaceuticals LP $8.65 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105810613 AstraZeneca Pharmaceuticals LP $125.00 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108362072 ABBVIE INC. $34.92 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108362074 ABBVIE INC. $21.20 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108362076 ABBVIE INC. $20.10 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108362078 ABBVIE INC. $30.20 05/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108362080 ABBVIE INC. $20.41 06/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108362082 ABBVIE INC. $12.56 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117710566 Amgen Inc. $21.15 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119207661 Otsuka America Pharmaceutical, Inc. $14.92 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120615044 Alkermes, Inc. $13.71 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133710599 Gilead Sciences, Inc. $121.81 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141606917 Merck Sharp & Dohme LLC $20.27 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141606919 Merck Sharp & Dohme LLC $16.26 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141976968 Merck Sharp & Dohme LLC $19.52 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.